Sarah Kerr, Edward O'Leary, Elizabeth DeWitt, Douglas Mah, Mark Alexander, John Kheir, Eric Feins, Edward Walsh, John Triedman, Audrey Dionne
{"title":"先天性心脏病患者术后早期消融的有效性和安全性。","authors":"Sarah Kerr, Edward O'Leary, Elizabeth DeWitt, Douglas Mah, Mark Alexander, John Kheir, Eric Feins, Edward Walsh, John Triedman, Audrey Dionne","doi":"10.1016/j.hrthm.2024.08.061","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.</p><p><strong>Objective: </strong>To describe the efficacy and safety of early post-operative ablation.</p><p><strong>Methods: </strong>Retrospective series of patients who underwent EPS within 12 months of surgery for congenital heart disease (CHD) between 2000-2021. Procedural outcome included complete or partial success, failure or empirical ablation and complications. Long-term outcome included arrhythmia recurrence and burden according to a 12-point clinical arrhythmia severity score (documented arrhythmia, arrhythmia severity, cardioversion, antiarrhythmic medication).</p><p><strong>Results: </strong>From 28,902 surgeries during the study period, 24 (0.1%) patients underwent EPS within 3 months of surgery and 26 (0.1%) 3-12 months after surgery. Most patients had great (n=27, 50%) or moderate (n=21, 42%) CHD complexity. Mechanisms of arrhythmias included intraatrial reentrant tachycardia (n=23, 46%), ectopic atrial tachycardia (n=13, 26%), accessory pathway (n=6, 12%), atrioventricular nodal reentrant tachycardia (n=7, 14%), twin atrioventricular node (n=1, 2%), atrial fibrillation (n=1, 2%), junctional ectopic tachycardia (n=1, 2%) and ventricular tachycardia (n=2, 4%). Procedure was acutely successful in 41 (82%) patients, empiric in 5 (10%) and unsuccessful in 4 (8%). Complications occurred in 4 patients (major in 1, moderate in 1, minor in 2). Recurrence of arrhythmia was documented in 27 (54%) patients, although the burden of arrhythmia was significantly reduced.</p><p><strong>Conclusion: </strong>A minority of patient require early post-operative EPS and ablation. For those, the procedure can be performed with reasonable acute success and manageable morbidity even in critically ill patients with complex surgical anatomy.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Early Post-Operative Ablation in Patients with Congenital Heart Disease.\",\"authors\":\"Sarah Kerr, Edward O'Leary, Elizabeth DeWitt, Douglas Mah, Mark Alexander, John Kheir, Eric Feins, Edward Walsh, John Triedman, Audrey Dionne\",\"doi\":\"10.1016/j.hrthm.2024.08.061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.</p><p><strong>Objective: </strong>To describe the efficacy and safety of early post-operative ablation.</p><p><strong>Methods: </strong>Retrospective series of patients who underwent EPS within 12 months of surgery for congenital heart disease (CHD) between 2000-2021. Procedural outcome included complete or partial success, failure or empirical ablation and complications. Long-term outcome included arrhythmia recurrence and burden according to a 12-point clinical arrhythmia severity score (documented arrhythmia, arrhythmia severity, cardioversion, antiarrhythmic medication).</p><p><strong>Results: </strong>From 28,902 surgeries during the study period, 24 (0.1%) patients underwent EPS within 3 months of surgery and 26 (0.1%) 3-12 months after surgery. Most patients had great (n=27, 50%) or moderate (n=21, 42%) CHD complexity. Mechanisms of arrhythmias included intraatrial reentrant tachycardia (n=23, 46%), ectopic atrial tachycardia (n=13, 26%), accessory pathway (n=6, 12%), atrioventricular nodal reentrant tachycardia (n=7, 14%), twin atrioventricular node (n=1, 2%), atrial fibrillation (n=1, 2%), junctional ectopic tachycardia (n=1, 2%) and ventricular tachycardia (n=2, 4%). Procedure was acutely successful in 41 (82%) patients, empiric in 5 (10%) and unsuccessful in 4 (8%). Complications occurred in 4 patients (major in 1, moderate in 1, minor in 2). Recurrence of arrhythmia was documented in 27 (54%) patients, although the burden of arrhythmia was significantly reduced.</p><p><strong>Conclusion: </strong>A minority of patient require early post-operative EPS and ablation. For those, the procedure can be performed with reasonable acute success and manageable morbidity even in critically ill patients with complex surgical anatomy.</p>\",\"PeriodicalId\":12886,\"journal\":{\"name\":\"Heart rhythm\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2024-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart rhythm\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.hrthm.2024.08.061\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2024.08.061","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Efficacy and Safety of Early Post-Operative Ablation in Patients with Congenital Heart Disease.
Background: Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.
Objective: To describe the efficacy and safety of early post-operative ablation.
Methods: Retrospective series of patients who underwent EPS within 12 months of surgery for congenital heart disease (CHD) between 2000-2021. Procedural outcome included complete or partial success, failure or empirical ablation and complications. Long-term outcome included arrhythmia recurrence and burden according to a 12-point clinical arrhythmia severity score (documented arrhythmia, arrhythmia severity, cardioversion, antiarrhythmic medication).
Results: From 28,902 surgeries during the study period, 24 (0.1%) patients underwent EPS within 3 months of surgery and 26 (0.1%) 3-12 months after surgery. Most patients had great (n=27, 50%) or moderate (n=21, 42%) CHD complexity. Mechanisms of arrhythmias included intraatrial reentrant tachycardia (n=23, 46%), ectopic atrial tachycardia (n=13, 26%), accessory pathway (n=6, 12%), atrioventricular nodal reentrant tachycardia (n=7, 14%), twin atrioventricular node (n=1, 2%), atrial fibrillation (n=1, 2%), junctional ectopic tachycardia (n=1, 2%) and ventricular tachycardia (n=2, 4%). Procedure was acutely successful in 41 (82%) patients, empiric in 5 (10%) and unsuccessful in 4 (8%). Complications occurred in 4 patients (major in 1, moderate in 1, minor in 2). Recurrence of arrhythmia was documented in 27 (54%) patients, although the burden of arrhythmia was significantly reduced.
Conclusion: A minority of patient require early post-operative EPS and ablation. For those, the procedure can be performed with reasonable acute success and manageable morbidity even in critically ill patients with complex surgical anatomy.
期刊介绍:
HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability.
HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community.
The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.